Carole Sable, M.D., has been appointed chief medical officer at SCYNEXIS. Dr. Sable most recently served as vice president at Merck & Co., initially as franchise integrator in Infectious Diseases, and more recently as vice president of project leadership and management in neurosciences and ophthalmology.   Prior to Merck, Dr. Sable served as chief medical officer of Novexel SA and president of Novexel Inc., the U.S. subsidiary, where she was responsible for the clinical development of two an...